Completed PHASE4 INTERVENTIONAL 1-arm NCT02176356

Patient Satisfaction Study of Combined Facial Treatment With BOTOX® Cosmetic, JUVÉDERM® and LATISSE® (HARMONY Study)

Sponsor: Allergan

Conditions Crow's Feet Lines Facial Rhytides Glabellar Lines Nasolabial Fold

Interventions JUVÉDERM® ULTRA PLUS XC JUVÉDERM® ULTRA XC JUVÉDERM® VOLUMA® XC bimatoprost ophthalmic solution 0.03% onabotulinumtoxinA

Updated 7 times since 2017 Last updated: Dec 19, 2018 Started: Jun 30, 2014 Primary completion: May 3, 2015 Completion: May 3, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Crow's Feet Lines and Facial Rhytides and is currently completed. Allergan leads this study, which shows 7 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Feb 2019 — Jan 2021 [monthly]

Completed PHASE4
Jun 2018 — Feb 2019 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Jun 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Allergan

Data source: Allergan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Los Angeles, United States